Anti Mitochondrial Antibody (AMA) - IFA

AMA by IFA (anti‑mitochondrial antibodies detected by indirect immunofluorescence) are autoantibodies that produce a characteristic granular cytoplasmic mitochondrial staining. They are a key diagnostic marker for primary biliary cholangitis, seen in roughly 90% of cases, and indicate autoimmune bile‑duct injury. Positive results require clinical correlation with symptoms, liver tests, and more specific serology or hepatology referral.

High AMH usually means a larger ovarian follicle pool and can indicate polycystic ovary syndrome (PCOS). It often predicts a strong response to ovarian stimulation but doesn’t guarantee egg quality or pregnancy. High AMH may raise the risk of ovarian hyperstimulation during IVF. Discuss results with a gynecologist or fertility specialist for tailored testing, monitoring and treatment options.

A positive anti‑mitochondrial antibody (AMA) indicates the immune system is making antibodies against mitochondrial components. It’s most strongly linked to primary biliary cholangitis (PBC) and supports that diagnosis when cholestatic liver tests or symptoms are present. Low‑level AMAs can occur with other autoimmune diseases or in older adults. Clinical correlation and further testing (AMA subtypes, liver function, imaging or biopsy) are needed.

Anti‑mitochondrial antibodies (AMA) are most strongly linked to primary biliary cholangitis (PBC). They can also appear in PBC–autoimmune hepatitis overlap syndromes and, less commonly, in other autoimmune diseases such as systemic sclerosis, Sjögren’s syndrome and rheumatoid arthritis, and in some chronic liver conditions. Detection warrants hepatology evaluation and further autoimmune workup.

A positive antimitochondrial antibody (AMA) most commonly indicates primary biliary cholangitis (PBC). AMAs can also appear with PBC–autoimmune hepatitis overlap, autoimmune hepatitis, chronic viral hepatitis (e.g., hepatitis C), other systemic autoimmune diseases (Sjögren’s, systemic sclerosis, rheumatoid arthritis, autoimmune thyroid disease), cholestatic/biliary disorders, and occasionally in older healthy individuals or drug‑related liver injury.

Normal AMA (anti‑mitochondrial antibody) result is negative or undetectable. Most labs consider titers below about 1:40 or antibody concentrations under the assay reference (commonly <20 U/mL) as normal. Positive or higher titers suggest autoimmune liver disease such as primary biliary cholangitis and should prompt further evaluation by a clinician. Interpretation depends on the assay and lab reference ranges.